Risk factors for grade 3 or 4 gamma-glutamyl transferase elevation in HIV/hepatitis C virus-coinfected patients

被引：6
|
作者：
Bani-Sadr, Firouze [1 ]
Miailhes, Patrick [2 ]
Rosenthal, Eric [3 ]
Yazdanpanah, Yazdan [4 ]
Boyer, Laurence [5 ]
Zucman, David [6 ]
Cacoub, Patrice [7 ]
Perronne, Christian [8 ]
Pol, Stanislas [9 ]
Carrat, Fabrice [1 ]
机构：
[1] Univ Paris 06, Grp Hosp Univ Est, INSERM, U 707, Paris, France
[2] Ctr Hosp Univ, Hotel Dieu, Lyon, France
[3] Ctr Hosp Univ Nice, Nice, France
[4] Ctr Hosp Tourcoing, Tourcoing, France
[5] Ctr Hos Univ Nancy, Nancy, France
[6] Hop Foch, Suresnes, France
[7] Univ Paris 06, Grp Hosp Univ Est, UMR 7087, Paris, France
[8] Univ Versailles, Ctr Hosp Univ Raymond Poincare, Garches, France
[9] Univ Paris 05, Grp Hosp Univ Ouest, INSERM, U370, Paris, France
来源：
AIDS | 2008年 / 22卷 / 10期
关键词：
D O I：
10.1097/QAD.0b013e3282fbd203
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1234 / 1236
页数：3
相关论文
共 50 条
  • [1] Gamma Glutamyl Transferase Elevation in HIV/Hepatitis C Virus-Coinfected Patients During Interferon-Ribavirin Combination Therapy
    Bani-Sadr, Firouze
    Lapidus, Nathanael
    Rosenthal, Eric
    Gerard, Laurence
    Foltzer, Adeline
    Perronne, Christian
    Cacoub, Patrice
    Pol, Stanislas
    Carrat, Fabrice
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (04) : 429 - +
  • [2] Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients
    Bollepalli, Srigayatri
    Mathieson, Kathleen
    Bay, Curt
    Hillier, Amy
    Post, John
    Van Thiel, David H.
    Nadir, Abdul
    SEXUALLY TRANSMITTED DISEASES, 2007, 34 (06) : 367 - 370
  • [3] Lipid abnormalities in HIV/hepatitis C virus-coinfected patients
    Bedimo, R.
    Ghurani, R.
    Nsuami, M.
    Turner, D.
    Kvanli, M-B
    Brown, G.
    Margolis, D.
    HIV MEDICINE, 2006, 7 (08) : 530 - 536
  • [4] Safety of statin therapy in HIV/hepatitis C virus-coinfected patients
    Milazzo, Laura
    Menzaghi, Barbara
    Corvasce, Stefano
    Bonfanti, Paolo
    Rusconi, Stefano
    Ridolfo, Anna Lisa
    Antinori, Spinello
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 258 - 260
  • [5] Risk factors for grade 3-4 liver enzyme elevation in HIV and hepatitis C coinfected patients on combination antiretroviral therapy
    Chihrin, S.
    Antoniou, T.
    Raboud, J.
    Shen, S.
    Govan, V.
    Fletcher, D.
    Rachlis, A.
    Kovacs, C.
    Crouzat, F.
    Tilley, D.
    Chang, B.
    Saskin, R.
    Loutfy, M. R.
    AIDS PATIENT CARE AND STDS, 2007, 21 (07) : 469 - 478
  • [6] Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin
    Bani-Sadr, Firouze
    Goderel, Isabelle
    Lapidus, Nathanael
    Driss, Henda
    Simon, Anne
    Rosenthal, Eric
    Morand, Patrice
    Lunel-Fabiani, Francoise
    Pol, Stanislas
    Cacoub, Patrice
    Perronne, Christian
    Carrat, Fabrice
    AIDS, 2008, 22 (11) : 1385 - 1387
  • [7] The role of insulin resistance in HIV/hepatitis C virus-coinfected patients
    Eslam, Mohammed
    Lopez-Cortes, Luis F.
    Romero-Gomez, Manuel
    CURRENT OPINION IN HIV AND AIDS, 2011, 6 (06) : 553 - 558
  • [8] HIV/Hepatitis C Virus-Coinfected Patients: Is There a Better Marker for Atherogenicity?
    Manickam, Palaniappan
    Mogrovejo, Estela
    Krishnamoorthi, Rajesh
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (05) : 745 - 745
  • [9] Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada
    Brunet, L.
    Moodie, E. E. M.
    Cox, J.
    Gill, J.
    Cooper, C.
    Walmsley, S.
    Rachlis, A.
    Hull, M.
    Klein, M. B.
    HIV MEDICINE, 2016, 17 (01) : 36 - 45
  • [10] HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels
    Gonzalez, SA
    Liu, RC
    Edlin, BR
    Jacobson, IM
    Talal, AH
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (05) : 582 - 589
12345